Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057951417> ?p ?o ?g. }
- W2057951417 endingPage "1572" @default.
- W2057951417 startingPage "1559" @default.
- W2057951417 abstract "With the limited strategies for curative treatment of castration-resistant prostate cancer (CRPC), public interest has focused on the potential prevention of prostate cancer. Recent studies have demonstrated that an angiotensin II receptor blocker (ARB) has the potential to decrease serum prostate-specific antigen (PSA) level and improve performance status in CRPC patients. These facts prompted us to investigate the direct effects of ARBs on prostate cancer growth and progression.Transgenic rat for adenocarcinoma of prostate (TRAP) model established in our laboratory was used. TRAP rats of 3 weeks of age received ARB (telmisartan or candesartan) at the concentration of 2 or 10 mg/kg/day in drinking water for 12 weeks. In vitro analyses for cell growth, ubiquitylation or reporter gene assay were performed using LNCaP cells.We found that both telmisartan and candesartan attenuated prostate carcinogenesis in TRAP rats by augmentation of apoptosis resulting from activation of caspases, inactivation of p38 MAPK and down-regulation of the androgen receptor (AR). Further, microarray analysis demonstrated up-regulation of estrogen receptor β (ERβ) by ARB treatment. In both parental and androgen-independent LNCaP cells, ARB inhibited both cell growth and AR-mediated transcriptional activity. ARB also exerted a mild additional effect on AR-mediated transcriptional activation by the ERβ up-regulation. An intervention study revealed that PSA progression was prolonged in prostate cancer patients given an ARB compared with placebo control.These data provide a new concept that ARBs are promising potential chemopreventive and chemotherapeutic agents for prostate cancer." @default.
- W2057951417 created "2016-06-24" @default.
- W2057951417 creator A5007636706 @default.
- W2057951417 creator A5016135291 @default.
- W2057951417 creator A5042940004 @default.
- W2057951417 creator A5045069355 @default.
- W2057951417 creator A5053869192 @default.
- W2057951417 creator A5063870659 @default.
- W2057951417 creator A5065633333 @default.
- W2057951417 creator A5075958648 @default.
- W2057951417 creator A5085955274 @default.
- W2057951417 date "2012-03-16" @default.
- W2057951417 modified "2023-10-14" @default.
- W2057951417 title "Therapeutic targeting of angiotensin II receptor type 1 to regulate androgen receptor in prostate cancer" @default.
- W2057951417 cites W1527092679 @default.
- W2057951417 cites W1565276921 @default.
- W2057951417 cites W1964387349 @default.
- W2057951417 cites W1969403506 @default.
- W2057951417 cites W1969875009 @default.
- W2057951417 cites W1977315722 @default.
- W2057951417 cites W1979858258 @default.
- W2057951417 cites W1984056355 @default.
- W2057951417 cites W1995753814 @default.
- W2057951417 cites W1996203273 @default.
- W2057951417 cites W1997348862 @default.
- W2057951417 cites W1999082394 @default.
- W2057951417 cites W2008076845 @default.
- W2057951417 cites W2010004613 @default.
- W2057951417 cites W2013933084 @default.
- W2057951417 cites W2015363725 @default.
- W2057951417 cites W2017137859 @default.
- W2057951417 cites W2024613227 @default.
- W2057951417 cites W2031150814 @default.
- W2057951417 cites W2032986961 @default.
- W2057951417 cites W2033895529 @default.
- W2057951417 cites W2038191095 @default.
- W2057951417 cites W2038888590 @default.
- W2057951417 cites W2046598678 @default.
- W2057951417 cites W2058177423 @default.
- W2057951417 cites W2067153979 @default.
- W2057951417 cites W2071879495 @default.
- W2057951417 cites W2078338576 @default.
- W2057951417 cites W2084691406 @default.
- W2057951417 cites W2085587446 @default.
- W2057951417 cites W2095062731 @default.
- W2057951417 cites W2112392983 @default.
- W2057951417 cites W2135178747 @default.
- W2057951417 cites W2137992841 @default.
- W2057951417 cites W2138306471 @default.
- W2057951417 cites W2139677318 @default.
- W2057951417 cites W2141255350 @default.
- W2057951417 cites W2142080475 @default.
- W2057951417 cites W2151114651 @default.
- W2057951417 cites W2152411252 @default.
- W2057951417 cites W2155530804 @default.
- W2057951417 cites W2155941155 @default.
- W2057951417 cites W2162923066 @default.
- W2057951417 cites W2166112157 @default.
- W2057951417 cites W2168377000 @default.
- W2057951417 cites W2168509239 @default.
- W2057951417 cites W2169884964 @default.
- W2057951417 cites W2172201047 @default.
- W2057951417 cites W4232547688 @default.
- W2057951417 doi "https://doi.org/10.1002/pros.22505" @default.
- W2057951417 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22430461" @default.
- W2057951417 hasPublicationYear "2012" @default.
- W2057951417 type Work @default.
- W2057951417 sameAs 2057951417 @default.
- W2057951417 citedByCount "27" @default.
- W2057951417 countsByYear W20579514172012 @default.
- W2057951417 countsByYear W20579514172013 @default.
- W2057951417 countsByYear W20579514172014 @default.
- W2057951417 countsByYear W20579514172015 @default.
- W2057951417 countsByYear W20579514172016 @default.
- W2057951417 countsByYear W20579514172017 @default.
- W2057951417 countsByYear W20579514172018 @default.
- W2057951417 countsByYear W20579514172019 @default.
- W2057951417 countsByYear W20579514172020 @default.
- W2057951417 countsByYear W20579514172021 @default.
- W2057951417 countsByYear W20579514172023 @default.
- W2057951417 crossrefType "journal-article" @default.
- W2057951417 hasAuthorship W2057951417A5007636706 @default.
- W2057951417 hasAuthorship W2057951417A5016135291 @default.
- W2057951417 hasAuthorship W2057951417A5042940004 @default.
- W2057951417 hasAuthorship W2057951417A5045069355 @default.
- W2057951417 hasAuthorship W2057951417A5053869192 @default.
- W2057951417 hasAuthorship W2057951417A5063870659 @default.
- W2057951417 hasAuthorship W2057951417A5065633333 @default.
- W2057951417 hasAuthorship W2057951417A5075958648 @default.
- W2057951417 hasAuthorship W2057951417A5085955274 @default.
- W2057951417 hasConcept C121608353 @default.
- W2057951417 hasConcept C126322002 @default.
- W2057951417 hasConcept C134018914 @default.
- W2057951417 hasConcept C143998085 @default.
- W2057951417 hasConcept C170493617 @default.
- W2057951417 hasConcept C2779716603 @default.
- W2057951417 hasConcept C2779723316 @default.
- W2057951417 hasConcept C2780036600 @default.